Three dimensional flow field inside compressor rotor, including blade boundary layers

The space marching code was modified in order to be able to predict the flow field inside a rotor passage, including the blade and hub wall boundary layers. The basic changes incorporated are modifications of the equations so that the code can handle three dimensional configurations with changes in the radial direction (for example changes in stagger angle, blade camber and thickness), extensions and modifications in order to implement a physically realistic turbulence model such as a k sigma model and an algebraic Reynolds stress model

Three dimensional flow field inside compressor rotor, including blade boundary layers

The flow in a turbomachinery blade passage has a predominant flow direction. The viscous diffusion in the streamwise direction is usually small and the elliptic influence is transmitted upstream through the pressure field. Starting with a guessed pressure field, it is possible to converge on the full elliptic solution by iterating between a parabolic solution and an iteration of the pressure field. The main steps of the calculation are given. The blade boundary layers which are three dimensional with laminar, transitional, turbulent, and separation zones are investigated. The kinetic energy is analyzed, and the dissipation equation is presented. Measurements were made of the three dimensional flow inside an axial flow compressor passage

Inclusiones parasitarias compatibles con Ehrlichia spp. Y Hepatozoon canis concomitantes en un neutrófilo

Se describe el caso clínico de una Cócker de 5 años de edad que llegó a nuestro centro veterinario con sintomatología compatible con ehrlichiosis, detectándose, en un frotis sanguíneo, la presencia en un mismo neutrófilo de una mórula de Ehrlichia y un gametocito de Hepatozoon canis. El animal respondió favorablemente al tratamiento con doxiciclina, dipropionato de imidocarb y atropina. La última reorganización taxonómica del género Ehrlichia ha dividido este género en tres; género Anaplasma, género Neorickettsia y género Ehrlichia, de forma que el clínico veterinario debe conocer las especies de Ehrlichia más frecuentes en su zona de trabajo, la sintomatología asociada y los hallazgos de laboratorio típicos de cada especie para poder llegar a un diagnóstico etiológico final de ehrlichiosis. La serología (junto a otras pruebas de laboratorio) es el método más utilizado para el diagnóstico final de ehrlichiosis, siendo necesario conocer bien sus beneficios y limitaciones porque nos puede llevar a diagnosticar fundamentalmente, falsos negativos. Además, es difícil saber con exactitud qué especie de Ehrlichia ha provocado la enfermedad debido a las reacciones serológicas cruzadas entre algunas especies próximas filogenéticamente. Por eso, con el fin de conocer exactamente la especie de Ehrlichia involucrada en la infección, se puede recurrir a la ayuda de técnicas de diagnóstico molecular.

Rubisco activity in Mediterranean species is regulated by the chloroplastic CO2 concentration under water stress

Water stress decreases the availability of the gaseous substrate for ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) by decreasing leaf conductance to CO2. In spite of limiting photosynthetic carbon assimilation, especially in those environments where drought is the predominant factor affecting plant growth and yield, the effects of water deprivation on the mechanisms that control Rubisco activity are unclear. In the present study, 11 Mediterranean species, representing different growth forms, were subject to increasing levels of drought stress, the most severe one followed by rewatering. The results confirmed species-specific patterns in the decrease in the initial activity and activation state of Rubisco as drought stress and leaf dehydration intensified. Nevertheless, all species followed roughly the same trend when Rubisco activity was related to stomatal conductance (gs) and chloroplastic CO2 concentration (Cc), suggesting that deactivation of Rubisco sites could be induced by low Cc, as a result of water stress. The threshold level of Cc that triggered Rubisco deactivation was dependent on leaf characteristics and was related to the maximum attained for each species under non-stressing conditions. Those species adapted to low Cc were more capable of maintaining active Rubisco as drought stress intensified

Clinical Efficacy and Safety of Fanhdi®, a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study

Prophylaxis; Von willebrand diseaseProfilaxis; Enfermedad de von willebrandProfilaxi; Malaltia de von willebrandObjective To evaluate the efficacy and safety of a plasma-derived factor VIII concentrate containing von Willebrand Factor (pdVWF/FVIII) in standard clinical practice in von Willebrand Disease (VWD) patients. Methods A retrospective, multicentric, observational study of VWD patients treated with Fanhdi®, a pdVWF/FVIII concentrate, from January 2011 to December 2017 was conducted at 14 centers in Spain. Efficacy and safety were evaluated for acute bleeding episodes, for prevention of bleeding in surgeries, and for secondary long-term prophylaxis. Results Seventy-two eligible patients, type 1, 2, 3 VWD (25%/38.9%/36.1%) were treated for spontaneous and traumatic bleeding (140 episodes, n = 41 patients), to prevent surgical bleeding (69 episodes, n = 43 patients); and for secondary long-term prophylaxis (18 programs, n = 13 patients). Replacement therapy with pdVWF/FVIII showed an excellent to good clinical efficacy in 96.7% of the bleeding episodes, 100% during surgical procedures and 100% during prophylaxis. No adverse events (AEs), nor serious AEs related to the product were observed. Conclusions Fanhdi® was effective, safe and well tolerated in the management of bleeding episodes, the prevention of bleeding during surgeries, and for secondary long-term prophylaxis in VWD patients.This work was supported by Grifols, manufacturer of the pdVWF/FVIII, Fanhdi®

Vps3 and Vps8 control integrin trafficking from early to recycling endosomes and regulate integrin-dependent functions

Recycling endosomes maintain plasma membrane homeostasis and are important for cell polarity, migration, and cytokinesis. Yet, the molecular machineries that drive endocytic recycling remain largely unclear. The CORVET complex is a multi-subunit tether required for fusion between early endosomes. Here we show that the CORVET-specific subunits Vps3 and Vps8 also regulate vesicular transport from early to recycling endosomes. Vps3 and Vps8 localise to Rab4-positive recycling vesicles and co-localise with the CHEVI complex on Rab11-positive recycling endosomes. Depletion of Vps3 or Vps8 does not affect transferrin recycling, but delays the delivery of internalised integrins to recycling endosomes and their subsequent return to the plasma membrane. Consequently, Vps3/8 depletion results in defects in integrin-dependent cell adhesion and spreading, focal adhesion formation, and cell migration. These data reveal a role for Vps3 and Vps8 in a specialised recycling pathway important for integrin trafficking

Mesophyll diffusion conductance to CO 2: An unappreciated central player in photosynthesis

Mesophyll diffusion conductance to CO 2 is a key photosynthetic trait that has been studied intensively in the past years. The intention of the present review is to update knowledge of g m, and highlight the important unknown and controversial aspects that require future work. The photosynthetic limitation imposed by mesophyll conductance is large, and under certain conditions can be the most significant photosynthetic limitation. New evidence shows that anatomical traits, such as cell wall thickness and chloroplast distribution are amongst the stronger determinants of mesophyll conductance, although rapid variations in response to environmental changes might be regulated by other factors such as aquaporin conductance.Gaps in knowledge that should be research priorities for the near future include: how different is mesophyll conductance among phylogenetically distant groups and how has it evolved? Can mesophyll conductance be uncoupled from regulation of the water path? What are the main drivers of mesophyll conductance? The need for mechanistic and phenomenological models of mesophyll conductance and its incorporation in process-based photosynthesis models is also highlighted.The study was financially supported by the Estonian Ministry of Science and Education (grant SF1090065s07), the Spanish Ministry of Science and Innovation through projects BFU2008-01072 (MEFORE), AGL2009-11310/AGR, BFU2011-23294 (MECOME) and CGL2009-13079-C02-01 (PALEOISOTREE), and the European Commission through European Regional Fund (the Estonian Center of Excellence in Environmental Adaptation), and the Marie Curie project MC-ERG-246725 (FP7). J.P.F. is supported by the Ramón y Cajal program (RYC-2008-02050). A.G. had a Swiss National Science Fellowship (PA00P3_126259). M.M.B. and C.R.W are supported by Future Fellowships from the Australian Research Council (FT0992063 and FT100100024). C.D. was supported by a grant from the French government and by the cooperation project Tranzfor (Transferring Research between EU and Australia–New Zealand on Forestry and Climate Change, PIRSES-GA-2008-230793) funded by the European Union

Clinical Efficacy and Safety of Fanhdi^®, a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study

Objective: To evaluate the efficacy and safety of a plasma-derived factor VIII concentrate containing von Willebrand Factor (pdVWF/FVIII) in standard clinical practice in von Willebrand Disease (VWD) patients. Methods: A retrospective, multicentric, observational study of VWD patients treated with Fanhdi®, a pdVWF/FVIII concentrate, from January 2011 to December 2017 was conducted at 14 centers in Spain. Efficacy and safety were evaluated for acute bleeding episodes, for prevention of bleeding in surgeries, and for secondary long-term prophylaxis. Results: Seventy-two eligible patients, type 1, 2, 3 VWD (25%/38.9%/36.1%) were treated for spontaneous and traumatic bleeding (140 episodes, n = 41 patients), to prevent surgical bleeding (69 episodes, n = 43 patients); and for secondary long-term prophylaxis (18 programs, n = 13 patients). Replacement therapy with pdVWF/FVIII showed an excellent to good clinical efficacy in 96.7% of the bleeding episodes, 100% during surgical procedures and 100% during prophylaxis. No adverse events (AEs), nor serious AEs related to the product were observed. Conclusions: Fanhdi® was effective, safe and well tolerated in the management of bleeding episodes, the prevention of bleeding during surgeries, and for secondary long-term prophylaxis in VWD patientsThe author(s) disclosed receipt of the followingfinancial support forthe research, authorship, and/or publication of this article: This workwas supported by Grifols, manufacturer of the pdVWF/FVIII,Fanhdi